FDA Inspection 785352 — Mark Brody
The FDA completed an inspection of Mark Brody on May 22, 2012 in Delray Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 22, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Delray Beach, FL (United States)
Additional Details
Clinical Investigator (CI)